Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

Smith, John W ; Buyse, Marc E ; Rastogi, Priya ; Geyer, Charles E., Jr ; Jacobs, Samuel A ; Patocskai, Erica J ; Robidoux, André ; Conlin, Alison K ; Ansari, Bilal ; Keogh, George P ; Stella, Philip J ; Gross, Howard M ; Lord, Raymond S ; Polikoff, Jonathan A ; Mauquoi, Celine ; Mamounas, Eleftherios P ; Swain, Sandra M ; Wolmark, Norman

VCU Scholars Compass 2017

Full text available